The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods
about
A review of malaria vaccine clinical projects based on the WHO rainbow tableDNA immunization as a technology platform for monoclonal antibody inductionEffect of vaccine administration modality on immunogenicity and efficacy.DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge InfectionInfluenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferretsAvian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetA consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza virusesImmunogenicity and protective efficacy of recombinant M2e.Hsp70c (Hsp70(359-610)) fusion protein against influenza virus infection in mice.Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans.Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).Prospects for developing an effective particle-mediated DNA vaccine against influenza.Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses.Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen.Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.The influence of delivery vectors on HIV vaccine efficacyCD8 T-cell activation in mice injected with a plasmid DNA vaccine encoding AMA-1 of the reemerging Korean Plasmodium vivaxRemoving N-terminal sequences in pre-S1 domain enhanced antibody and B-cell responses by an HBV large surface antigen DNA vaccine.The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responsesLive, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virusA trail blazed through DNA vaccine, noninvasive vaccine, and innate-adaptive immunity duo.Technical transformation of biodefense vaccines.Immune response to dna vaccine expressing transferrin binding protein a gene of Pasteurella multocida.Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.Neutrophils are Essential in Short Hairpin RNA of Indoleamine 2,3- Dioxygenase Mediated-antitumor EfficiencyCross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years.DNA immunization.Electroporation for DNA immunization: clinical application.DNA Immunization for HIV Vaccine Development.Co-expression of the Bcl-xL antiapoptotic protein enhances the induction of Th1-like immune responses in mice immunized with DNA vaccines encoding FMDV B and T cell epitopes.Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B.Identification of Aim2 as a sensor for DNA vaccines.Potent monoclonal antibodies against Clostridium difficile toxin A elicited by DNA immunizationDNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer model.Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection.
P2860
Q21034112-DCB444DB-144F-451B-9398-464709C311F2Q26751432-929884CA-2B95-4F12-AD9B-E67B0AAC5A50Q27692376-51ADBF5D-7503-4AA5-A67B-31C89DD2FD97Q28547011-D5749E20-1274-4F67-8E46-5F6215DD9C4BQ28742787-BAC7B471-5BD5-41FA-BF39-0D6AA101A58AQ30227194-650400F5-107F-4EAC-9EDE-165466A27B86Q30228657-0C390358-100E-4FF5-BCCC-0142FC7D2EF8Q30366089-DDCA4255-4836-40EE-8118-6E5E7FEA5A70Q30368929-0CE7090F-ABAC-4409-BB5B-871DAF5527E3Q30372481-9F3D6DE9-0FFB-4825-A247-C6ABF5169A24Q30379200-4327B2C6-A5E6-4C1D-BEB1-E84BF70899EFQ30380300-0EC94767-9E43-45C3-BAA1-84C9100E2348Q30382097-C00355E4-FD1C-4223-9185-8B15E89050A7Q30411149-235A4153-8250-4588-881F-F425BEDDC348Q30418612-B7C42B5E-7D96-4145-A8CE-51CE96E7E9BBQ33613943-11C2F7AF-24FA-4C23-85EB-CCFEE581A67AQ33631293-273F8045-E645-4682-95A4-937A23C6B669Q33698142-611ADE61-478C-4536-942E-178F48C7B191Q34077543-3CFDD8AC-5522-4D5D-A595-441876615FE4Q34717746-23FB9773-6571-4DAB-8DDE-FC3E7D204E0DQ36109563-1FF73709-C62E-4C1C-9354-591C9369EB40Q36256348-121C7B55-8521-4BBE-81A8-4B5BF8D3794DQ36900058-D7359110-E356-47DC-A842-756E279FFDECQ36978423-EBE2FE33-B450-4C2F-B5F6-0B7C766AA00FQ37058898-7690EC6C-0E75-4999-B4DC-3AA6F0F1591DQ37162315-43D81C9E-E110-4BB2-810E-D61D977A394BQ37351412-030AAF3A-8221-4C66-8113-69223ADD53F9Q37507487-00CBCA18-F486-4053-AA4C-0A739DE95F75Q37530450-DCA43083-9F0F-4066-9D5C-90BD5807943DQ37576264-F80EF507-7D4D-479D-9DB4-801A3233EF84Q37744992-16DFDC19-3957-4DA5-9348-0F4B7B938894Q38581981-7CD7D132-26F9-4BDC-A93C-80CB14483DC0Q39181986-094FA36B-7AAE-4ED6-A833-38F3C613800CQ40039860-370D52CB-546F-4147-83D9-C5DB3CC2CC7DQ40160424-3A9196A2-9D56-4DFF-BE96-B53A35102C7FQ41222915-7EF63CBB-ED78-4E17-AD25-56470048F805Q41609361-1A4F3C06-4106-4110-92BE-BF9C6D7D2328Q41899304-993E2A05-DCD5-40CE-8620-147B102324CBQ42202805-AD40DE7A-050A-42CD-830B-A934D7F4EFE7Q52356828-BBC8CC9C-B405-4D72-A91B-7760CCF5D6E3
P2860
The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The relative immunogenicity of ...... oporation and gene gun methods
@en
The relative immunogenicity of ...... poration and gene gun methods.
@nl
type
label
The relative immunogenicity of ...... oporation and gene gun methods
@en
The relative immunogenicity of ...... poration and gene gun methods.
@nl
prefLabel
The relative immunogenicity of ...... oporation and gene gun methods
@en
The relative immunogenicity of ...... poration and gene gun methods.
@nl
P2093
P2860
P1433
P1476
The relative immunogenicity of ...... oporation and gene gun methods
@en
P2093
P2860
P304
P356
10.1016/J.VACCINE.2008.02.033
P407
P577
2008-03-06T00:00:00Z